A Phase 4 interventional study of HCG injection and No intervention in Infertility (IVF Patients), sponsored by Fertility Center of Las Vegas. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-01.
Sponsored by Fertility Center of Las Vegas · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies testing Chorionic Gonadotropin in Infertility — 4 open to participants now, 4 under way, 2 of them phase 3. Chorionic Gonadotropin · Infertility.
Among the 40 studies testing Chorionic Gonadotropin in Infertility, this one is the 12th largest by planned enrollment, is the only one that started in 2025, is one of 18 in phase 4, and was the 39th registered.
2,089 studies on the registry are indexed under Infertility; 356 are open to participants now.
Browse Infertility studies →4 of the 40 studies testing Chorionic Gonadotropin in Infertility are open now, in 5 countries. Recruiting first, the newest first:
Georgios Papadakis · Sites in Switzerland
Ages 16–65 · Men only
The University of Hong Kong · Sites in China
Ages 18–42 · Women only
LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro · Sites in Uganda, Ukraine
Ages 18–40 · Women only
By country, each count listing its studies:
Chorionic Gonadotropin: first FDA approval 1973 (CHORIONIC GONADOTROPIN). What it is approved for, and how studies give it, is on its page →
Of the 234 Infertility studies recruiting now, 43 (18%) set no upper age limit and 185 (79%) stop at 75 or younger; 27 take children under 18; 76 take healthy volunteers.
This study: 18 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 7 · Phase 4 18
First in 2003; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 220 is above the median of 134 across 1,414 interventional studies indexed under Infertility.
Median enrollment 135 across the 40 interventional studies. Of the 26 that completed or were terminated, 2 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 40 have an industry lead sponsor. The 10 most frequent:
Fertility Center of Las Vegas is the lead sponsor of 7 studies on the registry; 3 are open to participants now.
Fertility Center of Las Vegas has 4 studies filed under Infertility — fewer than ten, so there is no comparison to draw.
1 of the studies testing Chorionic Gonadotropin in Infertility that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05586802Phase 3Georgios PapadakisSex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome | 2027-04-30 |
Add it to your calendar (.ics) → With an account.
Among the 40 studies testing Chorionic Gonadotropin in Infertility, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.
The current study is designed to carefully isolate the effect of a corpus luteum by ensuring that the presence or absence of a corpus luteum is the only difference between two study arms. This should be reliably achieved by administering an injection of hCG in one study arm, while the other study arm has identical treatment except for omitting the hCG.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group receives one injection of hCG.
Drug: HCG injection
This arm receives no hCG.
Other: No intervention
5000 IU hCG injection
No hCG administered in this group.
Blood pressure
Mean arterial pressure measured in third trimester of pregnancy
Time frame: Third trimester of pregnancy
Plan to share: No — No current plan to do so in approved protocol.
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Dec 2027, 30 months after the start.
Of 81 phase 4 interventional studies under Infertility, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 82. This study's planned 30 months is close to that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Chorionic Gonadotropin
Fertility Center of Las Vegas